Home > Back to Publisher > Report Information

Intranasal Drug Delivery - US Market Trends & Analysis

BizAcumen, Inc.
November 1, 2009
149 Pages - SKU: BZAC2522028

Abstract Table of Contents Related Reports

Countries covered: United States

The US intranasal drug delivery market is witnessing an expansion of therapeutic applications from the delivery of conventional local therapeutic drugs to the delivery of systemic therapeutic drugs. The future of the technology hinges onto the effective exploitation of the fact that the nose offers an en-route that bypasses the blood-brain barrier through the olfactory region. The market also stands enthused by the continuous research and development activities, which are gradually opening up opportunities in new therapeutic areas, such as, osteoporosis, pain management, vitamin B12 deficiency, smoking cessation, migraines, nocturnal enuresis, rheumatoid arthritis, sexual dysfunction, cancer therapy, insulin-dependent diabetes, and epilepsy.

These and other market data and trends are presented in "Intranasal Drug Delivery: US Market Trends & Analysis" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

1. METHODOLOGY: Study Reliability and Reporting Limitations; Disclaimers; Quantitative Techniques & Reporting Level
2. GLOBAL MARKET OVERVIEW AND OUTLOOK: Drug Delivery: A Quick Primer; Nasal Drug Delivery Devices & Equipments Preservative Free Systems (P.F.S.); Traditional Vs Advanced Intranasal Drug Delivery Devices; Market for Nasal Spray Devices in the US; GSK Wields the Leadership Scepter in the US Intranasal Drugs Market
3. MARKET DYNAMICS: Innovation in Drug Delivery: A Talisman for Success; Controlled Release Technology is the Buzz Word; Target-Specific Delivery Devices: Of Critical Value; Safety & Cost: Primary Growth Drivers; Preservatives Losing Sheen in Nasal Spray Formulations; Multi-Dose Containers Evolve to Offer Resistance Against Microbial Contamination; Bioavailability: An Important Facet of Intranasal Drug Delivery; Mixed Opinions on Efficiency of Calcitonin Nasal Spray; Nasal Preparations Gaining Foothold in Cough and Allergic Categories; Patent Expiries Impact Market Opportunities
4. PRODUCT FACTS
5. RECENT TECHNOLOGICAL DEVELOPMENTS: New-Generation Technologies and Devices
6. CORPORATE DEVELOPMENTS: Zelos Therapeutics Collaborates with Aegis Therapeutics; ImmuneRegen BioSciences Partners with LRRI; Avamys™ Nasal Spray Receives Approval in Europe; PMI-150 Receives Canadian Patent; Nastech Enrolls 551 Patients for Phase 2 Trials of PYY3-36 Nasal Spray; USFDA Approves FluMist® for Young Children; USFDA Approves Veramyst Nasal Spray for Individuals Aged Two Years and Above; Kurve Technology Inks Agreement with Schering-Plough; MedImmune Clarifies FDA Observations; FluMist(R) Receives FDA Approval for Refrigerated Formulation; Nastech Regains Rights for PTH1-34 Nasal Spray; NASONEX(R) Receives Ease-of-Use Commendation from Arthritis Foundation; Aegis Therapeutics Establishes Cedar Therapeutics Inc.; EMEA Provides Encouraging Feedback for Avamys™ Nasal Spray; Kurve Technologies Introduces Blog on Nasal Drug Delivery; Archimedes Pharma Commences Phase III Trials for NasalFent®; Archimedes Presents New Clinical Data on NasalFent®; LigoCyte Commences Clinical Trials for Intranasal Norovirus Vaccine; Javelin Pharmaceuticals Reveals Phase 2 Study Results for PMI-100/150; Javelin Pharmaceuticals Commences Phase III Studies for PMI-150; Nastech Commences Phase 2 Trials for Insulin Nasal Spray; ACAAI Reveals Results for Trials of Nasacort® AQ Nasal Spray in Children
7. MAJOR PLAYERS: Aegis Therapeutics LLC (USA); Alza Corporation (USA); AptarGroup, Inc. (USA); Archimedes Pharma Limited. (UK); AstraZeneca Plc (UK); Bayer Consumer Care (USA); Bespak Plc (UK); GlaxoSmithKline Plc (UK); Intranasal Therapeutics, Inc. (USA); Javelin Pharmaceuticals, Inc (USA); Kurve Technology, Inc. (USA); MDRNA, Inc. (USA); Novartis AG (Switzerland); OptiNose AS (Norway); Pfizer, Inc. (USA); Rexam Plc (UK); Schering-Plough Corporation (USA); Sanofi-Aventis S.A. (France); Unigene Laboratories, Inc. (USA)
8. MARKET ANALYTICS: Table 1: The US Nasal Drug Delivery Market: Sales Of Top Six Nasal Formulations for The Year 2005 (In US$ Million); Table 2: Percentage Market Shares of Leading Intranasal Drug Delivery Players in the US - 2006; Table 3: Percentage Shares of Intranasal Drugs Manufacturer Value in the US - 2012; Table 4: Top 10 Nasal Sprays, Drops and Inhalers Brands Ranked by Dollar Sales Through Drug Stores in the US - 2008 (In US $ Million); Table 5: Top 10 Nasal Sprays, Drops and Inhalers Brands Ranked by Unit Sales through Drug Stores in the US - 2008 (In Thousand Units); Table 6: Top Five Nasal Sprays Ranked by Dollar Retail Sales in the US - 2008 (In US $ Million); Table 7: Projected Revenues for Intranasal Sexual Dysfunction Drugs in the US -2010, 2011 & 2012 (in US$ Million); Table 8: Intranasal Drug Delivery Market by Therapeutic Area in the US: 2007-2015 (Sales in US$ Million); Table 9: Percentage Breakdown of Intranasal Drug Delivery Market by Therapeutic Area in the US for the Years 2008 & 2012
COMPANIES PROFILED

More United States Drug Delivery Reports

Freedonia Focus on Implantable Medical Devices: United States by Freedonia Focus
This report discusses US demand for implantable medical devices for the years 2005 and 2010, with forecasts for 2015. Topics covered include market size, product ...

Implantable Medical Devices by Freedonia Group Inc
US demand to increase 7.7% annually through 2015 US demand for implantable medical devices will increase 7.7 percent annually to $52 billion in 2015. These ...

Freedonia Focus on Drug Delivery Products: United States by Freedonia Focus
This report discusses US drug delivery products demand for the years 2005 and 2010, with forecasts for 2015. Topics covered include market size, product and ...

Drug Delivery Systems by Freedonia Group Inc
US demand to rise 7.2% annually through 2015 US demand for drug delivery products is forecast to expand 7.2 percent annually to $133 billion in ...

US Market for Implantable Medical Devices by Taiyou Research
It is expected that the demand for implantable medical devices in the United States will increase by nearly 8.5 percent by 2015. Although weakened in ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

Intranasal Drug Delivery - US Market Trends & Analysis

Share this report

Other tasks

Research Assistance

Related Markets

Drug Delivery Reports

Free Alert Me service